fda warning letters compounded semaglutide october 2025 US warns online vendors to stop selling unapproved weight-loss drugs FDA warns consumers not to

A triple GLP-1 agonist (retatrutide) additionally activates the glucagon receptor (GCGR), adding hepatic lipolysis and thermogenesis to the classical incretin mechanism and producing the largest weight-loss signal observed in the class to date

So, this can mean losing 300 hairs a day compared to the 100 we typically lose under normal circumstances (yes, really)

These injections are given into the muscle, allowing your body to more fully absorb the nutrients than it would be able to take these supplements orally with pills or powder

Compounded semaglutide stored beyond its expiration date undergoes chemical degradation that reduces therapeutic potency by up to 1015% per month after the printed expiration